Kilter Group’s Teladoc Health TDOC Stock Holding History

Kilter Group’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-45	Closed	-$348	–	1484
2025 Q3	$348	Hold	45	–	–	﹤0.01%	1115
2025 Q2	$392	Buy	+45	New	+$326	﹤0.01%	1021

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Kilter Group's TDOC Position: Q4 2025 in Review

Kilter Group sold out of Teladoc Health (TDOC) in Q4 2025, closing a stake of 45 shares — an estimated $348 sold.

Kilter Group first reported a position in TDOC in Q2 2025 and held it in 2 quarters. The position peaked at $392 in Q2 2025. 344 funds tracked by Wall St. Rank hold TDOC as of Q4 2025.

Kilter Group reported no remaining Teladoc Health position as of Q4 2025 after selling out during the quarter.
Kilter Group sold 45 Teladoc Health shares in Q4 2025, an estimated $348.
Kilter Group first reported a position in Teladoc Health in Q2 2025 and held it in 2 quarters.
Kilter Group's Teladoc Health position peaked at $392 in Q2 2025.
344 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2025.

Based on Kilter Group's 13F filing for Q4 2025, filed 13 Feb 2026.